July 30, 2024 – Roche introduced the completion of the acquisition of LumiraDx’s Level of Care expertise, following receipt of all required antitrust and regulatory approvals. Roche will now start the total integration of the corporate’s modern multi-assay level of care platform and related R&D, operational and industrial websites into its world group. With this acquisition, Roche […]